Insulet Reports Third Quarter 2020 Revenue Increase of 22% Year-Over-Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Insulet (PODD) Tops Q3 EPS by 9c, Revenues Beat; Raises Revenue Guidance Growth Range
November 4, 2020 5:34 PM ESTInsulet (NASDAQ: PODD) reported Q3 EPS of $0.17, $0.09 better than the analyst estimate of $0.08. Revenue for the quarter came in at $234 million versus the consensus estimate of $221.68 million.
Third Quarter Financial Highlights:
Third quarter 2020 revenue of $234.0 million, up 21.8%, or 19.9% in constant currency1, compared to $192.1 million in the prior year, exceeds guidance of 13% to 15% on a constant currency basisTotal Omnipod revenue of $212.1 million, an increase of 19.7%, or 17.6% in constant currencyU.S. Omnipod revenue of $132.3 million, an increase of 20.9%International Omnipod revenue of $79.8 million, an increase of 17.7%, or 12.4% in constant... More